PT - JOURNAL ARTICLE AU - Sara J. Cromer AU - Chirag M. Lakhani AU - Deborah J Wexler AU - Sherri-Ann M. Burnett-Bowie AU - Miriam Udler AU - Chirag J. Patel TI - Geospatial Analysis of Individual and Community-Level Socioeconomic Factors Impacting SARS-CoV-2 Prevalence and Outcomes AID - 10.1101/2020.09.30.20201830 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.30.20201830 4099 - http://medrxiv.org/content/early/2020/09/30/2020.09.30.20201830.short 4100 - http://medrxiv.org/content/early/2020/09/30/2020.09.30.20201830.full AB - Background The SARS-CoV-2 pandemic has disproportionately affected racial and ethnic minority communities across the United States. We sought to disentangle individual and census tract-level sociodemographic and economic factors associated with these disparities.Methods and Findings All adults tested for SARS-CoV-2 between February 1 and June 21, 2020 were geocoded to a census tract based on their address; hospital employees and individuals with invalid addresses were excluded. Individual (age, sex, race/ethnicity, preferred language, insurance) and census tract-level (demographics, insurance, income, education, employment, occupation, household crowding and occupancy, built home environment, and transportation) variables were analyzed using linear mixed models predicting infection, hospitalization, and death from SARS-CoV-2.Among 57,865 individuals, per capita testing rates, individual (older age, male sex, non-White race, non-English preferred language, and non-private insurance), and census tract-level (increased population density, higher household occupancy, and lower education) measures were associated with likelihood of infection. Among those infected, individual age, sex, race, language, and insurance, and census tract-level measures of lower education, more multi-family homes, and extreme household crowding were associated with increased likelihood of hospitalization, while higher per capita testing rates were associated with decreased likelihood. Only individual-level variables (older age, male sex, Medicare insurance) were associated with increased mortality among those hospitalized.Conclusions This study of the first wave of the SARS-CoV-2 pandemic in a major U.S. city presents the cascade of outcomes following SARS-CoV-2 infection within a large, multi-ethnic cohort. SARS-CoV-2 infection and hospitalization rates, but not death rates among those hospitalized, are related to census tract-level socioeconomic characteristics including lower educational attainment and higher household crowding and occupancy, but not neighborhood measures of race, independent of individual factors.Competing Interest StatementA close family member of SJC is employed by a Johnson & Johnson company. CML is a consultant to XY.health, Inc. DJW reports serving on data monitoring committees for Novo Nordisk. CJP is a co-founder and consultant to XY.health, Inc.Funding StatementNo funding was provided directly in support of this work. This work was supported indirectly by the National Institutes of Health (grant numbers T32DK007028, NIDDK T32DK110919) and the National Science Foundation (grant number 1636870). The content is solely the responsibility of the authors and does not necessarily represent the views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and deemed exempt by the Institutional Review Board of Mass General Brigham.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.